Source: Annual Congress 2013 –Pneumonia and sepsis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. I. Dogrul, N. Bayraktar, S. Akcay (Ankara, Turkey). The role of procalcitonin (PCT) in differential diagnosis of pneumonia and pulmonary congestion associated with end-stage renal failure (ESRF). Eur Respir J 2013; 42: Suppl. 57, 303

Member's Comments

No comment yet.

Related content which might interest you: Procalcitonin (PCT) and C-reactive protein (CRP) as markers of the differential diagnosis of severe community acquired pneumonia (sCAP) Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Lung function in patients with chronic renal failure (CRF) Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19. Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Accuracy of inflammatory markers to distinguish between pneumonia and pulmonary embolism in acute settings Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Inflammatory biomarkers as outcome predictors of acute respiratory failure on top of chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Pulmonary hypertension (PH) in chronic hemodialysis (CHD) patients is associated with inflammatory markers and volume overload Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Pulmonary hypertension in end-stage renal disease and post renal transplantation patients Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)? Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Pulmonary dysfunctions in end stage chronic renal failure (ESCRF) children on regular hemodialysis: possible risk factors Source: Annual Congress 2007 - Paediatric respiratory physiology in health and disease Year: 2007 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016